Page last updated: 2024-08-26

septacidin and krn 5500

septacidin has been researched along with krn 5500 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujisawa, S; Luo, JM; Maksumova, L; Muratkhodjaev, F; Naito, K; Nakamura, S; Ohnishi, K; Ohno, R; Pan, L; Shigeno, K; Shinjo, K; Takeshita, A; Yoshida, H; Zhang, WJ1
Mizumura, Y1

Reviews

1 review(s) available for septacidin and krn 5500

ArticleYear
[Spicamycin derivative].
    Nihon rinsho. Japanese journal of clinical medicine, 2006, Volume: 64, Issue:2

    Topics: Animals; Antineoplastic Agents; Clinical Trials, Phase I as Topic; Humans; Micelles; Polymers; Purine Nucleosides; Rats

2006

Other Studies

1 other study(ies) available for septacidin and krn 5500

ArticleYear
Spicamycin and KRN5500 induce apoptosis in myeloid and lymphoid cell lines with down-regulation of bcl-2 expression and modulation of promyelocytic leukemia protein.
    Japanese journal of cancer research : Gann, 2000, Volume: 91, Issue:6

    Topics: Antibiotics, Antineoplastic; Apoptosis; Cell Differentiation; Cell Survival; Down-Regulation; Hematopoietic Stem Cells; HL-60 Cells; Humans; Neoplasm Proteins; Nuclear Proteins; Promyelocytic Leukemia Protein; Proto-Oncogene Proteins c-bcl-2; Purine Nucleosides; Transcription Factors; Tumor Cells, Cultured; Tumor Suppressor Proteins

2000